Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman

The prevalence of osteoporosis is about three times greater in people living with HIV than in the general population. Bisphosphonates are the only class of antiresorptive drugs which have proved to be safe and effective in HIV patients. However, bisphosphonates are not recommended in women of child...

Full description

Bibliographic Details
Main Authors: E. Marasco, M. Mussa, F. Motta, F. Bobbio-Pallavicini, R. Maserati, C. Montecucco, L. Bogliolo
Format: Article
Language:English
Published: PAGEPress Publications 2021-04-01
Series:Reumatismo
Subjects:
HIV
Online Access:https://www.reumatismo.org/index.php/reuma/article/view/1358